These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

139 related items for PubMed ID: 2994556

  • 1. Penetration of sulbactam-ampicillin and clavulanic acid-amoxicillin into the pelvic peritoneum.
    Houang ET, Colley N, Chapman M.
    Antimicrob Agents Chemother; 1985 Jul; 28(1):165-6. PubMed ID: 2994556
    [Abstract] [Full Text] [Related]

  • 2. Penetration of sulbactam and ampicillin into peritoneal fluid.
    Wise R, Donovan IA, Andrews JM, Drumm J, Bennett S.
    Antimicrob Agents Chemother; 1983 Aug; 24(2):290-2. PubMed ID: 6314889
    [Abstract] [Full Text] [Related]

  • 3. Comparative pharmacokinetics and tissue penetration of sulbactam and ampicillin after concurrent intravenous administration.
    Brown RM, Wise R, Andrews JM, Hancox J.
    Antimicrob Agents Chemother; 1982 Apr; 21(4):565-7. PubMed ID: 6282211
    [Abstract] [Full Text] [Related]

  • 4. Comparative pharmacokinetics of sulbactam/ampicillin and clavulanic acid/amoxycillin in human volunteers.
    Hampel B, Lode H, Bruckner G, Koeppe P.
    Drugs; 1988 Apr; 35 Suppl 7():29-33. PubMed ID: 3220007
    [Abstract] [Full Text] [Related]

  • 5. The penetration of amoxycillin/clavulanic acid into peritoneal fluid.
    Wise R, Donovan IA, Drumm J, Andrews JM, Stephenson P.
    J Antimicrob Chemother; 1983 Jan; 11(1):57-60. PubMed ID: 6826486
    [Abstract] [Full Text] [Related]

  • 6. Comparative activities of the beta-lactamase inhibitors YTR 830, sodium clavulanate, and sulbactam combined with amoxicillin or ampicillin.
    Aronoff SC, Jacobs MR, Johenning S, Yamabe S.
    Antimicrob Agents Chemother; 1984 Oct; 26(4):580-2. PubMed ID: 6097169
    [Abstract] [Full Text] [Related]

  • 7. Comparative efficacies of amoxicillin-clavulanic acid and ampicillin-sulbactam against experimental Bacteroides fragilis-Escherichia coli mixed infections.
    Gisby J, Beale AS.
    Antimicrob Agents Chemother; 1988 Dec; 32(12):1830-3. PubMed ID: 3072924
    [Abstract] [Full Text] [Related]

  • 8. [Stability of beta-lactamase inhibitors and beta-lactam antibiotics in parenteral formulations as well as in body fluids and tissue homogenates. Comparison of sulbactam, clavulanic acid, ampicillin and amoxicillin].
    Wildfeuer A, Räder K.
    Arzneimittelforschung; 1991 Jan; 41(1):70-3. PubMed ID: 2049115
    [Abstract] [Full Text] [Related]

  • 9. The parenteral kinetics of ampicillin/sulbactam in man.
    Foulds G, Knirsch AK, Stankewich JP, Weidler DR.
    Int J Clin Pharmacol Res; 1985 Jan; 5(2):79-86. PubMed ID: 2991150
    [Abstract] [Full Text] [Related]

  • 10. Beta-lactamase inhibitors: another approach to overcoming antimicrobial resistance.
    Parker RH, Eggleston M.
    Infect Control; 1987 Jan; 8(1):36-40. PubMed ID: 3028975
    [Abstract] [Full Text] [Related]

  • 11. Relative efficacy of tazobactam, sulbactam and clavulanic acid in enhancing the potency of ampicillin against clinical isolates of Enterobacteriaceae.
    Pfaller M, Barry A, Fuchs P, Gerlach E, Hardy D, McLaughlin J.
    Eur J Clin Microbiol Infect Dis; 1993 Mar; 12(3):200-5. PubMed ID: 8389705
    [Abstract] [Full Text] [Related]

  • 12. Biliary pharmacokinetics of sulbactam plus ampicillin in humans.
    Morris DL, Ubhi CS, Robertson CS, Brammer KW.
    Rev Infect Dis; 1986 Mar; 8 Suppl 5():S589-92. PubMed ID: 3026008
    [Abstract] [Full Text] [Related]

  • 13. Oral bioavailability of ampicillin and amoxycillin alone and bound in fixed proportions to sulbactam and clavulanic acid.
    Desager JP, Costermans J, Van Nieuwenhuyze Y, Harvengt C.
    J Int Med Res; 1989 Mar; 17(6):532-8. PubMed ID: 2628130
    [Abstract] [Full Text] [Related]

  • 14. Pharmacokinetics of sulbactam/ampicillin in humans: a review.
    Foulds G.
    Rev Infect Dis; 1986 Mar; 8 Suppl 5():S503-11. PubMed ID: 3025997
    [Abstract] [Full Text] [Related]

  • 15. Concentration of sulbactam and ampicillin in serum and the myometrium.
    Schwiersch U, Lang N, Wildfeuer DA.
    Drugs; 1986 Mar; 31 Suppl 2():26-8. PubMed ID: 3013570
    [Abstract] [Full Text] [Related]

  • 16. Comparison of four beta-lactamase inhibitors in combination with ampicillin against Mycobacterium tuberculosis.
    Sorg TB, Cynamon MH.
    J Antimicrob Chemother; 1987 Jan; 19(1):59-64. PubMed ID: 3030999
    [Abstract] [Full Text] [Related]

  • 17. In vitro activity of aminopenicillins combined with sulbactam, clavulanic acid, or amdinocillin against bacteria isolated from patients with complicated urinary tract infections.
    Naber KG, Wittenberger R.
    Rev Infect Dis; 1986 Jan; 8 Suppl 5():S604-8. PubMed ID: 3026011
    [Abstract] [Full Text] [Related]

  • 18. Possible prevention of in vitro selection of resistant Streptococcus pneumoniae by beta-lactamase inhibitors.
    Carsenti-Etesse H, Durant J, De Salvador F, Bensoussan M, Bensoussan F, Pradier C, Bernard E, Mondain V, Thabaut A, Dellamonica P.
    Eur J Clin Microbiol Infect Dis; 1994 Dec; 13(12):1058-62. PubMed ID: 7889969
    [Abstract] [Full Text] [Related]

  • 19. [Sulbactam and clavulanic acid: studies of enzyme kinetics and synergism with ampicillin and mezlocillin].
    Cullmann W, Binder S, Stieglitz M.
    Immun Infekt; 1987 May; 15(3):103-9. PubMed ID: 3038733
    [Abstract] [Full Text] [Related]

  • 20. In vitro activities of the beta-lactamase inhibitors clavulanic acid, sulbactam, and tazobactam alone or in combination with beta-lactams against epidemiologically characterized multidrug-resistant Acinetobacter baumannii strains.
    Higgins PG, Wisplinghoff H, Stefanik D, Seifert H.
    Antimicrob Agents Chemother; 2004 May; 48(5):1586-92. PubMed ID: 15105109
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.